Antibiotic ineffective at preventing lung complication after stem cell transplant: Study – UPI.com
UPI.com |
Antibiotic ineffective at preventing lung complication after stem cell transplant: Study
UPI.com 9, 2017 — An antibiotic treatment intended to lower stem cell transplant patients’ risk of developing a respiratory complication appears to have backfired. French researchers explored the potential of administering the antibiotic azithromycin before … |
BioPharma-Reporter.com |
Pfizer chooses Sanford, North Carolina site for $100m gene therapy plant
BioPharma-Reporter.com According to North Carolina Governor Roy Cooper, Pfizer will spend $100m (€85m) on the new facility and has also committed $4m to support postdoctoral fellowships in North Carolina universities for training in gene therapy research. The project will … |
Science Daily |
Amniotic sac in a dish: Stem cells form structures that may aid of infertility research
Science Daily But scientists haven’t had a good way to explore the biology behind this phenomenon. Now, a new achievement using human stem cells could give researchers a chance to see what they couldn’t before, while avoiding ethical issues associated with studying … |
|
Pfizer commits $100M for a gene therapies plant in North Carolina
FiercePharma Pfizer committed to building a $100 million gene therapies plant in North Carolina and in exchange, North Carolina committed to providing the drugmaker with a quarter-million dollars’ worth of help. Pfizer will expand an 11,000-square-foot plant in … |
FierceBiotech |
Silverstein-backed startup will test gene therapy for Parkinson’s
FierceBiotech Regenxbio has joined forces with investment firm OrbiMed and a new nonprofit foundation to create Prevail Therapeutics, a startup focused on new biologics and gene therapies for Parkinson’s disease (PD). Prevail will draw on the expertise of the … Orbimed partner in search of a cure for Parkinson’s launches new gene therapy playerEndpoints News For Parkinson’s, Two Drugs Coming And One New Co as Prevail Starts in NYXconomy The Silverstein Foundation, REGENXBIO, and OrbiMed Launch Prevail TherapeuticsBusiness Wire (press release) CNBC all 6 news articles » |
Channel NewsAsia |
Outrage over S.Korean stem cell scandal official’s new post
Phys.Org But a decade ago Park was a key figure in a scandal involving the fabrication of research by prominent stem cell scientist Hwang Woo-Suk. “Her name is far from innovation. The name is rather a nightmare to science and technology workers,” a group of … Hwang Woo-Suk Collaborator’s Post Raises IreGenomeWeb |
Technology Networks |
CRISPR Used to Identify Genes Essential for Cancer Immunotherapy
Technology Networks A new study identifies genes that are necessary in cancer cells for immunotherapy to work, addressing the problem of why some tumors don’t respond to immunotherapy or respond initially but then stop as tumor cells develop resistance to immunotherapy. |
